BiotechTube
Home/ReAlta Life Sciences/Kia Motesharei, Ph.D.
KM

Kia Motesharei, Ph.D.

President & Chief Operating Officer

ReAlta Life Sciences

Therapeutic Areas

Neonatal NeurologyInflammatory Diseases

ReAlta Life Sciences Pipeline

DrugIndicationPhase
Pegtarazimod (RLS-0071)Neonatal Hypoxic-Ischemic Encephalopathy (HIE)Phase 2

Leadership Team at ReAlta Life Sciences

HB
Howard Berman, Ph.D.
Chief Executive Officer
View full ReAlta Life Sciences profile